MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Keiretsu Forum
Industry: Silicon Valley, California
PneumRx
Attachments
PneumRx
Parents
*Architects: Surgical Technology_Minimally Invasive & Natural Orifice Transluminal Endoscopic Surgery (NOTES) Technology
*Industry: Germany
*Portfolio Companies: Alta
Architects: Pulmonology, Respiratory
Industry: Silicon Valley, California
Children
Addresses unmet clinical needs in the interventional pulmonary/thoracic surgery market
and Newton, Mass.-based Spray Venture Partners (2011)
Broncus Technologies Inc
Develops medical devices for the treatment of lung conditions
Founded 2008
Has obtained $33 million in a third round of financing led by venture capital firms Forbion Capital Partners and Endeavour Vision.(2011)
Implantable device, the RePneu® Lung Volume Reduction Coil (LVRC™), is designed to improve lung function in patients with emphysema by reducing lung volume using minimally invasive means.
Medical device company PneumRx raises $33M (2011)
Mountain View, California
Others participating included Adams Street Partners, which has an office in Menlo Park
Patients are generally able to return home the next day.
PneumRx Inc Buys Key Assets from Broncus (2012)
PneumRx recently established a subsidiary in Germany, PneumRx GmbH, and has begun selling its device in Europe (2011)
San Francisco-based Telegraph Hill Partners and Alta Partners
Series C Investor(s) Endeavour Vision, Silicon Valley Bank, Adams Street Partners, Telegraph Hill Partners, Spray Venture Partners, Forbion Capital Partners, Alta Partners, Leader Ventures
The RePneu LVRC is implanted through a bronchoscope in a simple and short procedure, under conscious sedation or general anesthesia, using a proprietary Delivery System.